NRX Pharmaceuticals Inc. (B1Q) - Financials, balance sheet (quarterly)

1.22000 EUR

Last update May 23, 2:00 AM CEST

Market closed

Day range

1.22000

Previous close

1.22000

Open

1.22000

Access this stock data via API

NRX Pharmaceuticals Inc.

1.22

Financials

Balance sheet

Fiscal date	Mar 2025	Dec 2024	Sep 2024	Jun 2024
Total assets	7.6M	3.7M	4.5M	5.3M
Current assets	7.3M	3.3M	4.1M	4.9M
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	5.5M	1.4M	1.6M	1.9M
Other short term investments	—	—	—	—
Accounts receivable	—	—	—	—
Other receivables	—	—	6K	6K
Inventory	—	—	—	—
Prepaid assets	1.7M	1.9M	2.5M	3.0M
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	334K	349K	356K	384K
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	—	—	—	—
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	—	—	—
Investments and advances	—	—	—	—
Other non current assets	334K	349K	356K	384K
Total liabilities	32.8M	26.9M	23.3M	23.7M
Current liabilities	32.8M	21.9M	20.3M	23.7M
Accounts payable	4.3M	4.1M	4.9M	5.0M
Accrued expenses	4.9M	5.2M	5.1M	6.2M
Short term debt	8.4M	1.6M	3.7M	7.7M
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	550K	577K	—	—
Other current liabilities	14.6M	10.4M	6.6M	4.8M
Non current liabilities	0	5.0M	3.0M	0
Long term provisions	—	—	—	—
Long term debt	—	5.0M	3.0M	—
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	17K	15K	11K	11K
Retained earnings	-283.8M	-278.3M	-269.2M	-267.6M
Other shareholders equity	0	0	0	-3K
Total shareholders equity	-25.2M	-23.2M	-18.8M	-18.4M
Additional paid in capital	258.6M	255.0M	250.4M	249.2M
Treasury stock	—	—	—	—
Minority interest	—	—	—	—